Wolfgang Kothny

Effect of Oral Postmenopausal Hormone Replacement on Progression of Atherosclerosis

Peter Angerer, Stefan Störk, Wolfgang Kothny et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2001 · 241 citations · Full text

Medicine, Cardiology, Endocrinology +17

Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure

John J.V. McMurray, Piotr Ponikowski, Geremia B. Bolli et al. · JACC Heart Failure · 2017 · 162 citations · Full text

Medicine, Cardiology, Pharmacology +17

Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24‐week randomized placebo‐controlled trial

Valentina Lukashevich, Anja Schweizer, Q. Shao et al. · Diabetes Obesity and Metabolism · 2011 · 147 citations

Medicine, Pharmacology, Pharmacotherapy +15

An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials

Monica Ligueros‐Saylan, James E. Foley, Anja Schweizer et al. · Diabetes Obesity and Metabolism · 2010 · 145 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study

W. David Strain, Valentina Lukashevich, Wolfgang Kothny et al. · The Lancet · 2013 · 139 citations

Pharmacy, Geriatric Medicine, Pharmacotherapy +15